Long-term side-effects of targeted therapies in pediatric cancer patients
Thursday, February 7, 2013 - 16:00
in Health & Medicine
Already we know that molecularly targeted therapies may stunt the growth of pediatric patients, delay puberty or speed the onset of diabetes. And researchers are just now starting to ask about additional, sometimes unforeseen side-effects, potentially including more subtle issues such as neurocognitive, balance and motor defects.